-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Health care delivery infrastructure and patient management: POEM lacks features that
would significantly
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
January 01, 2012 - RYGB has both
restrictive and malabsorptive features.
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
December 05, 2013 - Mobi-C Plug & Fit cervical disc prosthesis
features. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Mobi-C Plug & Fit cervical disc prosthesis
features. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
December 01, 2013 - these patients, which increases patients’ risk of developing delirium and
infection.52 Other design features
-
www.ahrq.gov/sites/default/files/2024-02/cohen2-report.pdf
January 01, 2024 - how often
these risks result in potentially harmful errors that reach customers, rank which system features
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - Evidence for Importance of the Measure to Medicaid and/or CHIP
Comment on any specific features of this
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-134-fullreport.pdf
November 01, 2019 - Evidence for Importance of the Measure to Medicaid and/or CHIP
Comment on any specific features of this
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
February 01, 2020 - Evidence for Importance of the Measure to Medicaid and/or CHIP
Comment on any specific features of this
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-fullreport.pdf
July 01, 2019 - Evidence for Importance of the Measure to Medicaid and/or CHIP
Comment on any specific features of this
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0232-fullreport.pdf
February 01, 2020 - Evidence for Importance of the Measure to Medicaid and/or CHIP
Comment on any specific features of this
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-113-fullreport.pdf
May 01, 2018 - Evidence for Importance of the Measure to Medicaid and/or CHIP
Comment on any specific features of this
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/lung-cancer-screening
March 09, 2021 - Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study
-
hcup-us.ahrq.gov/db/nation/neds/NEDS_2006_Introductionv4.pdf
January 01, 2006 - One of the most
distinctive features of the NEDS is its large sample size, which allows for analysis
-
hcup-us.ahrq.gov/db/nation/neds/NEDS_2007_Introduction_v5.pdf
January 01, 2007 - One of the most
distinctive features of the NEDS is its large sample size, which allows for analysis
-
hcup-us.ahrq.gov/db/nation/neds/NEDS2008Introductionv3.pdf
November 01, 2015 - One of the most
distinctive features of the NEDS is its large sample size, which allows for analysis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_qPVhJ_u9tV9kyAejLM9TB
May 01, 2015 - Much of the
literature lacks information about
important features of the intervention,
such as whether
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KT7vaWK_JSDNNvEmUAjN8d
May 01, 2018 - Influence of study features and methods on
overdiagnosis estimates in breast and prostate cancer screening
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16812/prostate-models-overdiagnosis/pdf
May 01, 2018 - Influence of study features and methods on
overdiagnosis estimates in breast and prostate cancer screening
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-harms-of-screening-for-breast-cancer/breast-cancer-screening-january-2016
January 11, 2016 - Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening